Press Release

MALVERN, Pa., July 05, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced that Dr. Neal Walker, President & Chief Executive Officer, will present at Cantor Fitzgerald’s 2^nd Annual Healthcare Conference on Tuesday, July 12, 2016 at 2:30 p.m. Eastern Time.  The conference will be held at the Le Parker Meridien Hotel in New York, NY.

A live audio webcast of the Aclaris presentation may be accessed by visiting the “Investors” section of the Company’s website at www.aclaristx.com.  A replay of the webcast will be archived on the Aclaris website for 14 days following the presentation date.

About Aclaris
Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology.  Aclaris Therapeutics, Inc. is based in Malvern, Pennsylvania and more information can be found by visiting the company’s website at www.aclaristx.com.

Contact:
Aclaris Contact
Frank Ruffo
Chief Financial Officer
484-324-7933
investors@aclaristx.com

Investor Contact
Patricia L. Bank
Westwicke Partners
Managing Director
415-513-1284
patti.bank@westwicke.com

Media Contact
Mariann Caprino
TogoRun
917-242-1087
M.Caprino@togorun.com

Aclaris Therapeutics, Inc.